Facebook Twitter Linkedin NASDAQ Market NewsClick here to email authorNEXT STORYAgios to Present Updated Data from the Phase 1 Study of Vorasidenib in Non-enhancing Glioma in Oral Presentation at the American Society of Clinical Oncology Annual MeetingPREV STORYCidara Provides Corporate Update and Reports First Quarter 2020 Financial Results